Nitric oxide in health and disease of the nervous system

Molecular Psychiatry

Volumn 2, Issue 4, 1997, Pages 300-310

  Yun, H Y ^a,b   Dawson, V L ^a   Dawson, T M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chung Ang University   (South Korea)

Author keywords

Endothelium derived relaxing factor; Neurological diseases; Neurotoxicity; Neurotransmission; Nitric oxide synthase

Indexed keywords

EXCITOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL REGENERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 0030881495     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000272     Document Type: Review

References (146)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med 1993; 329: 2002-2012.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
3. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994; 14: 5147-5159.
4. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature 1988; 336: 385-388.
5. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-718.
6. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-228.
7. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992; 89: 6711-6715.
8. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992; 267: 6370-6374.
9. Meyer DJ. Enzymatic and non-enzymatic formation of nitric oxide. Nature Med 1995; 1: 1103.
10. Zweier JL, Wang PH, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nature Med 1995; 1: 804-809.
11. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994; 14: 5147-5159.
12. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992; 281: 627-630.
13. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 1992; 267: 24173-24176.
14. Culcasi M, Lafon-Cazal M, Pietri S, Bockaert J. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J Biol Chem 1994; 269: 12589-12593.
15. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996; 93: 6770-6774.
16. Dinerman JL, Steiner JP, Dawson TM, Dawson VL, Snyder SH. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 1994; 33: 1245-1251.
17. Bredt DS, Ferris CD, Snyder SH. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic: AMP-dependent protein kinase, protein kinase C, and calcium/calmodnlin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 1992; 267: 10976-10981.
18. Dawson TM, Steiner JP, Dawson JL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 9808-9812.
19. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-910.
20. Jaffrey SR, Snyder SH. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science 1996; 274: 774-777.
21. Lowenstein CJ, Alley KW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 9730-9734.
22. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 1993; 177: 1779-1784.
23. Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM, Dawson VL. Neuronal (Type I) nitric oxide synthase regulates NFκB activity and immunologic (Type II) nitric oxide synthase expression. Proc Natl Acad Sci USA 1997; 94: 2676-2680.
24. Aoki C, Fenstemaker S, Lubin M, Go CG. Nitric oxide synthase in the visual cortex of mononuclear monkeys as revealed by light and electron microscopic immunucytochemistry. Brain Res 1993; 620: 97-113.
25. Darius S, Wolf G, Huang PL, Fishman MC. Localization of NADPH-diaphorase/nitrc oxide synthase in the rat retina - an electron microscopic study. Brain Res 1995; 690: 231-235.
26. Standaert DC, Landwehrmeyer GB, Kerner JA, Penny JB, Young AB. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriaturn, neocortex, and hippocampus. Mol Brain Res 1996; 42: 89-102.
27. Ponting CP, Phillips C. DHR domains in syntrophins, neuronal NO synthases and other intracellular proteins. Trends Biochem Sci 1995; 20: 102-103.
28. Brenman JE, Chao DS, Xia HH, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in duchenne muscular dystrophy. Cell 1995; 82: 743-752.
29. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and 1-syntrophin mediated by PDZ domains. Cell 1996; 84: 757-767.
30. Crosbie RH, Chamberlain JS, Dawson TM, Dawson VL, Campbell KP. Nitric oxide synthase interaction with dystrophin glycoprotein complex. Mol Biol Cell 1995; 6 (suppl): 286A.
31. Chang WJ, Iannuccone ST, Lau KS, Masters BSS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG, Stull JT. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 1996; 93: 9142-9147.
32. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89: 444-448.
33. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-632.
34. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244.
35. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994; 269: 29409-29415.
36. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A. EPR characterization of moleular targets for NO in mammalian cells and organelles. FASEB J 1993; 7: 1124-1134.
37. Drapier JC, Hirling H, Wietzerbin J, Kaldy P, Kuhn LC. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J 1993; 12: 3643-3649.
38. Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, Werner-Felmayer G, Wachter H, Hentze MW. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthaso pathway. EMBO J 1993; 12: 3651-3657.
39. Jaffrey SR, Cohen NA, Rouault TA, Klausner RD, Snyder SH. The iron-responsive element binding protein: a target for synaptic actions of nitric oxide. Proc Natl Acad Sci USA 1994; 91: 12994-12998.
40. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
41. Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15: 53-59.
42. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487.
43. Mirza UA, Chait BT, Lander HM. Monitoring reactions of nitric oxide with peptides and proteins by electrospray ionization-mass spectrometry. J Biol Chem 1995; 270: 17185-17188.
44. Fagni L, Olivier M, Lafoncazal M, Bockaert J. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol Pharmacol 1995; 47: 1239-1247.
45. Dimmeler S, Lottspeich F, Brune B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1992; 267: 16771-16774.
46. Zhang J, Snyder SH. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 1992; 89: 9382-9385.
47. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-226.
48. Hess DT, Patterson SI, Smith DS, Skene JHP. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 1993; 366: 562-565.
49. Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci USA 1994; 91: 3191-3195.
50. Chang HY, Takei K, Sydor AM, Born T, Rusnak F, Jay DG. Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. Nature 1995; 376: 686-690.
51. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med 1993; 329: 2002-2012.
52. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768-770.
53. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MG. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273-1286.
54. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ, De Laet MH. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. New Engl J Med 1992; 327: 511-515.
55. Chung E, Curtis D, Chen G, Marsden PA, Twells R, Xu W, Gardiner M. Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis. Am J Hum Genetics 1996; 58: 363-370.
56. Mashimo H, He XD, Huang PL, Fishman MC, Goyal RK. Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. J Clin Invest 1996; 98: 8-13.
57. Burnett AL, Lowenstein GJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257: 401-403.
58. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New Engl J Med 1992; 326: 90-94.
59. Burnett AL, Calvin DC, Chamness SL, Liu JX, Dawson VL, Dawson TM, Snyder SH. Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nature Med 1997 (in press).
60. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52: 127-136.
61. Rezvani AH, Grady DR, Peek AE, Pucilowski O. Inhibition of nitric oxide synthesis attenuates alcohol consumption in two strains of alcohol-preferring rats. Pharmacol Biochem Behav 1995; 50: 265-270.
62. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 1994; 266: 1713-1717.
63. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995; 378: 383-386.
64. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, Fishman MC. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 1994; 265: 542-546.
65. Linden DJ, Dawson TM, Dawson VL. An evaluation of the nitric oxide/cGMP/cGMP-dependent protein kinase cascade in the induction of cerebellar long-term depression in culture. J Neurosci 1995; 15: 5098-5105.
66. Zerani M, Gobbetti A. NO sexual behavior in newts. Nature 1996; 382: 31.
67. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39.
68. Linden DJ, Connor JA. Long-term synaptic depression. Annu Rev Neurosci 1995; 18: 319-357.
69. Bohme GA, Bon C, Stutzmann JM, Doble A, Blanchard JC. Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol 1991; 199: 379-381.
70. Schuman EM, Madison DV. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 1991; 254: 1503-1516.
71. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 1991; 88: 11285-11289.
72. Haley JE, Wilcox GL, Chapman PF. The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992; 8: 211-216.
73. Arancio O, Kiebler M, Lee CJ, Lev-Ram V, Tsien RY, Kandel ER, Hawkins RD. Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell 1996; 87: 1025-1035.
74. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991; 349: 326-328.
75. Daniel H, Hemart N, Jaillard D, Crepel F. Long-term depression requires nitric oxide and guanosine 3′, 5′-cyclic monophosphate production in rat cerebellar Purkinje cells. Eur J Neurosci 1993; 5: 1079-1082.
76. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ER. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 1996; 87: 1015-1023.
77. Kantor DB, Lanzrein M, Stary SJ, Sandoval GM, Smith WB, Sullivan BM, Davidson N, Schuman EM. A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science 1996; 274: 1744-1748.
78. Muller U. Inhibition of nitric oxide synthase impairs a distinct form of long-term memory in the honeybee, Apis mellifera. Neuron 1996; 16: 541-549.
79. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ. Role of NO production in NMDA receptor-mediated neuro-transmitter release in cerebral cortex. Science 1994; 263: 973-977.
80. Hirsch DB, Steiner JP, Dawson TM, Mammen A, Hayek E, Snyder SH. Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Curr Biol 1993; 3: 749-754.
81. Seilicovich A, Duvilanski BH, Pisera D, Theas S, Gimeno M, Rettori V, McCann SM. Nitric oxide inhibits hypothalamic luteinizing hormone-releasing hormone release by releasing γ-aminobutyric acid. Proc Natl Acad Sci USA 1995; 92: 3421-3424.
82. 2+-independent synaptic vesicle release. Neuron 1994; 12: 1235-1244.
83. Ahmad I, Leinders-Zufall T, Kocsis JD, Shepherd GM, Zufall F, Barnstable CJ. Retinal ganglion cells express a cGMP-gated cation conductance activatable by nitric oxide donors. Neuron 1994; 12: 155-165.
84. Meffert MK, Calakos NC, Scheller RH, Schulman H. Nitric oxide modulates synaptic vesicle docking/fusion reactions. Neuron 1996; 16: 1229-1236.
85. Bredt DS, Snyder SH. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 1994; 13: 301-313.
86. Kalb RG, Agostini J. Molecular evidence for nitric oxide-mediated motor neuron development. Neuroscience 1993; 57: 1-8.
87. Williams CV, Nordquist D, McLoon SC. Correlation of nitric oxide synthase expression with changing patterns of axonal projections in the developing visual system. J Neurosci 1994; 14: 1746-1755.
88. Roskams AJ, Bredt DS, Dawson TM, Ronnett GV. Nitric oxide mediates the formation of synaptic connections in developing and regenerating olfactory receptor neurons. Neuron 1994; 13: 289-299.
89. Peunova N, Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 1995; 375: 68-73.
90. Kuzin B, Roberts I, Peunova N, Enikolopov G. Nitric oxide regulates cell proliferation during Drosophila development. Cell 1996; 87: 639-649.
91. Lander HM, Jacovina AT, Davis RJ, Tauras JM. Differential activation of mitogen-activated protein kinase by nitric oxide-related species. J Biol Chem 1996; 271: 19705-19709.
92. Yun HY, Gonzalez-Zulueta M, Dawson VL, Dawson TM. Glutamate-stimulated calcium activation of Ras/Erk pathway: mediation by nitric oxide. 1997 (submitted).
93. ras. J Biol Chem 1995; 270: 7017-7020.
94. Lander HM, Milbank AJ, Taurus JM, Hajjar DP, Hemstead BL, Schwartz GD, Kraemer RT, Mirza UA, Chait BT, Burk SC, Quilliam LA. Redox regulation of cell signalling. Nature 1996; 381: 380-381.
95. 2+-dependent route to Ras: mechanisms for neuronal survival, differentiation, and plasticity? Neuron 1996; 16: 233-236.
96. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effect of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
97. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297-311.
98. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634.
99. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmocol Sci 1990; 11: 379-387.
100. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13: 171-182.
101. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991; 88: 6368-6371.
102. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM. Resistance to neurotoxicity in cortical neuronal cultures from neuronal nitric oxide synthase deficient mice. J Neurosci 1996; 16: 2479-2487.
103. Demerle-Pallardy C, Lonchampt MO, Chabrier PE, Braquet P. Absence of implication of L-arginine/nitric oxide pathway on neu ronal cell injury induced by L-glutamate or hypoxia. Biochem Biophys Res Commun 1991; 181: 456-464.
104. Pauwels PJ, Leysen JE. Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus. Neurosci Lett 1992; 143: 27-30.
105. Regan RF, Renn KE, Panter SS. NMDA neurotoxicity in murine cortical cell cultures is not attenuated by hemoglobin or inhibition of nitric oxide synthesis. Neurosci Lett 1993; 153: 53-56.
106. Samdani A, Newcamp C, Resink A, Facchinetti F, Hoffman B, Dawson VL, Dawson TM. Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J Neurosci 1997 (in press).
107. Hewett SJ, Csernansky CA, Choi DW. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 1994; 13: 487-494.
108. Koh JY, Gwag BJ, Lobner D, Choi DW. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 1995; 268: 573-575.
109. Lindsay RM. Neurotrophic growth factors and neurodegonerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol Aging 1994; 15: 249-251.
110. Lindvall O, Kokaia Z, Bengzon J, Elmer E, Kukaia M. Neurotrophins and brain insults. Trends Neurosci 1994; 17: 490-496.
111. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Hunting-don's disease. Science 1985; 230: 561-563.
112. Koh JY, Peters S, Choi DW. Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science 1986; 234: 73-76.
113. Uemura Y, Kowall NW, Beal MF. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol 1990; 27: 620-625.
114. Hyman BT, Marzloff K, Wenniger JJ, Dawson TM, Bredt DS, Snyder SH. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann Neurol 1992; 32: 818-820.
115. Gonzalez-Zulueta M, Ensz LM, Mukhin G, Zwacka RM, Engelhardt JF, Oberley LW, Dawson VL, Dawson TM. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide mediated neurotoxicity. (submitted).
116. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266: 4244-4250.
117. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, Radomski MW, Moncada S. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994; 91: 6702-6706.
118. Dawson DA. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 1994; 6: 299-324.
119. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883-1885.
120. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-argine. J Cereb Blood Flow Metab 1996; 16: 981-987.
121. Yoshida T, Limmroth V, Irikura K, Moskowitz MA. The NOS inhibitor 7-nitroindazole decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 1994; 14: 924-929.
122. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 1996; 16: 981-987.
123. Dalkara T, Yoshida T, Irikura K, Moskowitz MA. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology 1994; 33: 1447-1452.
124. Iadecola C, Zhang F, Xu S, Casey R, Ross ME. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 1995; 15: 378-384.
125. Iadecola C. Bright and dark side of nitric oxide in ischemic brain injury. Trends Neurosci 1997; 20: 132-139.
126. 2 toxicity. Proc Natl Acad Sci USA 1992; 89: 9715-9719.
127. Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, Beal MF. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 1995; 15: 8419-8429.
128. Schultz JB, Matthews RT, Muqit MM, Browne SE, Beal MF. Inhibition of neuronal nitric: oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 1995; 64: 936-939.
129. Przedborski S, Jackon-Lewis V, Yokohama R, Shibata T, Dawson VL, Dawson TM. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 1996; 93: 4565-4571.
130. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Mathews RT, Beal MF. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced Parkinsonism in baboons. Nature Med 1996; 2: 1017-1021.
131. Dawson VL, Dawson TM, Uhl GR, Snyder SH. Human immuno-deficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90: 3256-3259.
132. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 1992; 66: 2217-2225.
133. Koka P, He KY, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE. Human immunodeficiency virus 1 envelope proteins induce interleukin 1 tumor necrosis factor alpha and nitric oxide in glial cultures derived from fetal neonatal and adult human brain. J Exp Med 1995; 182: 941-951.
134. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL. Induction of immunologic nitric oxide synthase in AIDS dementia. Science 1996; 274: 1917-1921.
135. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Mature 1994; 371: 336-339.
136. Dawson TM, Hung K, Dawson VL, Steiner JP, Snyder SH. Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase. Ann Neurol 1995; 37: 115-118.
137. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-1330.
138. Gaal JC, Smith KR, Pearson CK. Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosylation in cellular metabolism. Trends Biochem Sci 1987; 12: 129-130.
139. de Murcia G, Menissier-de Murcia J, Schreiber V. Poly(ADP-ribose) polymerase: molecular biological aspects. Bioessays 1991; 13: 455-462.
140. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994; 263: 687-689.
141. Cosi C, Suzuki H, Milani D, Facci L, Menegazzi M, Vantini G, Kanai Y, Skaper SD. Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 1994; 39: 38-46.
142. Wallis RA, Panizzon KL, Henry D, Wasterlain CG. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuroreport 1993; 5: 245-248.
143. Heller B, Wang ZQ, Wagner EF, Radons J, Burkle A, Fehsel K, Burkart V, Kolb H. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 1995; 270: 11176-11180.
144. Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 1995; 369: 136-139.
145. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal grafts. Proc Natl Acad Sci USA 1996; 93: 11853-11858.
146. + channels glutamate release and NMDA receptor mediated delayed neurodegeneration through nitric oxide formation. J Neurosci 1996; 16: 5004-5013.